Bayer Animal Health Helps Swine Producers Feed the World

Informations

• Publié par: bayer-healthcare
• Nombre de lectures: 10
• Langue: English

Extrait

Bayer Animal Health Helps Swine Producers

Feed the World

PR Newswire

JEJU, South Korea, June 10, 2012

JEJU,

South Korea

,

June 10, 2012

/PRNewswire/ --

- Leading animal health company puts future of swine

production on top of agenda at pivotal meeting

Bayer Animal Health used the occasion of the 22nd International Pig Veterinary

Society (IPVS) Congress in Jeju,

South Korea

, to reveal the latest programme of

activities aimed at transforming livestock production.

As part of their commitment to the advancement of knowledge in the livestock

community, Bayer Animal Health held the 4th International Bayer Pig

Symposium in Jeju on

June 10th

, giving more than 200 veterinarians and swine

producers from 19 countries access to the latest thinking on practical solutions

to the problems raised by global changes. This was followed by a Satellite

Symposium at the IPVS Congress with leading academic figures debating the

future of swine production in a world of increasing consumption and decreasing

natural resources.

Wolfgang Müller, Head of Global Marketing Farm Animal Products at Bayer

Animal Health said "At Bayer Animal Health, we are acutely aware of the

challenges facing the pig industry in the years to come: the need to deliver

increased productivity in a cost-effective manner while preserving resources

and protecting animal health and welfare are key issues. All parts of livestock

community need to work together to meet these challenges. With these

symposia and other events of their kind, we will continue to bring together local

knowledge, science, innovation and global expertise to help the livestock

community to survive and thrive in these challenging times."

Sharing local knowledge

The 4th International Bayer Pig Symposium, chaired by Dr Bent Nielsen,

Representative of the Swine Veterinary Association of

Denmark

, focused on

sharing local knowledge to deliver practical guidance for swine producers and

vets seeking to improve swine welfare and production now and for the future.

The Symposium was opened by Dr Kees Scheepens from FarmulaOne in

the

Netherlands

, who took the audience through the basics of the new Pig Signals

®

concept whilst Dr Joaquim Segalés from the Universitat Autònoma de

Barcelona, Spain

presented practical tips for designing swine vaccination

programmes that maximise results while minimizing costs. Dr Kyoungjin Kim of

the Pig and Health Vet Group in

South Korea

gave an update on the current

state of Porcine Epidemic Diarrhoea (PED) in

South Korea

, showing mortality

rates in suckling pigs were up to 100%. According to Dr Kim, a new trend is

being seen in PED infections in

South Korea

, with lower rates of mortality (20-

30% versus 80-100%) appearing in suckling piglets in the 2011/12 winter

season. However Dr Kim stressed that prevention is key to controlling PED, with

those applying bio-security concepts seeing reduced numbers of outbreaks.

Finally, Dr Anders Holm of the Odder Veterinary Practice in

Denmark

took the

audience through his efforts to raise awareness of coccidiosis infection in

China

with a 'lab-on-wheels', developed by Bayer Animal Health. Dr Holm toured

China

giving swine producers previously unattainable access to laboratory

facilities to assess the presence of coccidiosis on their farms. According to Dr

Holm, "Pig producers in

China

are very interested in exchanging experiences

with colleagues from abroad. I also believe that European producers could

learn from Chinese colleagues, as costs of buildings are reduced and diseases

not yet present in

Europe

are frequent in

China

."

'Feeding the world…or saving the planet?

At the Satellite Symposium on

June 11th

, the need for practical guidance on

maximising production value was debated by 400 veterinarians and swine

producers from around the world. Entitled 'Feeding the world…or saving the

planet?' the lively debate was chaired by Professor Arlette Laval, Professor of

Food Animal Medicine at Nantes Atlantic College of Veterinary Medicine.

The debate gave insights into the challenges and opportunities facing swine

production as population growth continues along with meat consumption levels.

Dr Osler Desouzart, owner of OD consulting in

Brazil

, presented the case for

science and technology delivering a 'Silent Green Revolution' to address the

inequalities in access to quality meat proteins.

Dr Desouzart said, "The world population is forecast to continue to grow until at

least 2100, but with growth focussed in the least developed areas of the planet,

fair distribution of food availability will become critical."

Dr Manfred J Kern from agriExcellence GmbH in

Germany

, examined the need

to balance environmental impact with large-scale pig production. According to

Dr Kern, the greatest challenge being faced by the livestock sector will be in

finding ways to minimise greenhouse gas emissions and develop a new form of

'carbon conscious pork' with a dramatically lower carbon footprint. "Veterinary

medicines will play a key role, not only in ensuring that we can keep pigs

healthy and thriving, but also in helping to safeguard resources by minimising

losses to disease or pandemics" said Dr Kern.

Vaccine hope for Classical Swine Fever

Bayer Animal Health also took the opportunity to present further information on

the development of their new vaccine for Classical Swine Fever (CSF). Posters

presented by Dr Maw-Shen of the National Chung Hsing University of

Taiwan

,

demonstrated positive efficacy results and prevention of horizontal

transmission of CSF.

Transforming Livestock Production

"Our activities around IPVS are a great example of our Transforming Livestock

Production commitment in action. We feel that all those who attended our

events have taken away a greater understanding of the future challenges they

will face, but with credible, concrete guidance on what they can do to step up

and meet these challenges: letting them know that we are partners in this

journey" said Wolfgang Müller.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of

health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of

Bayer AG with annual sales of

EUR 17.2 billion

(2011), is one of the world's

leading, innovative companies in the healthcare and medical products industry

and is based in Leverkusen,

Germany

. The company combines the global

activities of the Animal Health, Consumer Care, Medical Care and

Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop,

manufacture and market products that will improve human and animal health

worldwide. Bayer HealthCare has a global workforce of 55,700 employees (

Dec

31, 2011

) and is represented in more than 100 countries. Find more

information at http://www.bayerhealthcare.com.

With a turnover of EUR 1.190 million (2011) Bayer HealthCare's Animal Health

Division is one of the world's leading manufacturers of veterinary drugs. The

division manufactures and markets more than 100 different veterinary drugs

and care products for livestock and companion animals.

Forward-Looking Statements

This release may contain forward-looking statements based on current

assumptions and forecasts made by Bayer Group or subgroup management.

Various known and unknown risks, uncertainties and other factors could lead to

material differences between the actual future results, financial situation,

development or performance of the company and the estimates given here.

These factors include those discussed in Bayer's public reports which are

available on the Bayer website at http://www.bayer.com. The company

assumes no liability whatsoever to update these forward-looking statements or

to conform them to future events or developments.